Dear Client,
As part of our ongoing commitment to ensuring the security of your online trading experience, we would like to inform you of our protocol for addressing any suspicious activities observed on your trading account
Should you notice any irregularities or suspect unauthorized access to your account, we kindly request that you take immediate action by following the steps outlined below:
Send an Email Please send an email to stoptrade@acml.in from your registered email ID. In the email, briefly outline the suspicious activity you have observed.
Phone Call Alternatively, you can call us at 07968101000 Ext: 1 from your registered mobile number. This will enable us to address your concerns promptly.
When contacting us, please ensure you provide the following details:
By providing this information, you enable us to swiftly investigate and take appropriate measures to safeguard your account.
Your security and peace of mind are of utmost importance to us, and we appreciate your cooperation in maintaining the integrity of your trading account.
Divis Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 3989.3, up 3.79% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.29% on the day, quoting at 22503.9. The Sensex is at 74098.62, down 0.32%. Divis Laboratories Ltd has added around 18.45% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has added around 1.29% in last one month and is currently quoting at 18878.15, up 0.7% on the day. The volume in the stock stood at 7.02 lakh shares today, compared to the daily average of 6.38 lakh shares in last one month.
The benchmark May futures contract for the stock is quoting at Rs 4020, up 3.66% on the day. Divis Laboratories Ltd is up 23.19% in last one year as compared to a 25.61% gain in NIFTY and a 51.85% gain in the Nifty Pharma index.
The PE of the stock is 74.75 based on TTM earnings ending December 23.
Powered by Capital Market - Live News